Filtros de búsqueda

Lista de obras de Ann-Lii Cheng

A critical evaluation of the preventive effect of antiviral therapy on the development of hepatocellular carcinoma in patients with chronic hepatitis C or B: a novel approach by using meta-regression

artículo científico publicado en 2012

A pathway for tumor necrosis factor-alpha-induced Bcl10 nuclear translocation. Bcl10 is up-regulated by NF-kappaB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus

artículo científico publicado en 2006

A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors

artículo científico publicado en 2013

A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment

scientific article published on 24 August 2016

A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies.

artículo científico publicado en 2014

A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan

artículo científico publicado en 2010

A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinoma

artículo científico publicado en 2007

A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis

artículo científico publicado en 2015

A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy

artículo científico publicado en 2013

A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer

artículo científico publicado en 2016

A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial

artículo científico publicado en 2008

A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement.

artículo científico publicado en 2016

AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-κB activation

artículo científico publicado en 2014

Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells

artículo científico publicado en 2011

Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma

artículo científico publicado en 2008

Adaptation of international guidelines for metastatic colorectal cancer: an asian consensus

artículo científico publicado en 2014

Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approach

artículo científico publicado en 2010

An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer

artículo científico publicado en 2006

Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method – Analysis of 2010 Taiwanese patients

article

Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial

scholarly article by Chia-Chi Lin et al published 26 August 2006 in Investigational New Drugs

Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

artículo científico publicado en 2017

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

artículo científico publicado en 2010

Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia

artículo científico

Aspirin antagonizes the cytotoxic effect of methotrexate in lung cancer cells

artículo científico publicado en 2013

Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy

artículo científico publicado en 2017

Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma

article

Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer

artículo científico publicado en 2016

BCL10GFP fusion protein as a substrate for analysis of determinants required for mucosa-associated lymphoid tissue 1 (MALT1)-mediated cleavage

artículo científico publicado en 2012

BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer

artículo científico publicado en 2016

Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells

artículo científico publicado en 2002

Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis

artículo científico publicado en 2015

Bevacizumab preconditioning followed by Etoposide and Cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy

artículo científico publicado en 2015

Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: a multicenter phase II study

artículo científico publicado en 2013

Beware imposters: MA-1, a novel MALT lymphoma cell line, is misidentified and corresponds to Pfeiffer, a diffuse large B-cell lymphoma cell line-A reply: despite the same 8-code STR, MA-1 and Pfeiffer are cytogenetically diverse

artículo científico publicado en 2013

Bortezomib enhances radiation-induced apoptosis in solid tumors by inhibiting CIP2A.

artículo científico publicado en 2011

Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway

artículo científico publicado en 2009

Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A.

artículo científico publicado en 2011

Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells

artículo científico publicado en 2008

CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells

artículo científico publicado en 2010

CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cells

artículo científico publicado en 2012

CYP19 genetic polymorphism haplotype AASA is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer

artículo científico publicado en 2013

Cancerous inhibitor of protein phosphatase 2A mediates bortezomib-induced autophagy in hepatocellular carcinoma independent of proteasome

artículo científico publicado en 2013

Carbonic anhydrase III promotes transformation and invasion capability in hepatoma cells through FAK signaling pathway

artículo científico publicado en 2008

Changes in Tumor Density in Patients with Advanced Hepatocellular Carcinoma Treated with Sunitinib

artículo científico publicado en 2011

Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions

artículo científico publicado en 2010

Chemotherapy alone is an alternative treatment in treating localized primary ocular adnexal lymphomas

artículo científico publicado en 2017

Chemotherapy alone versus surgery followed by chemotherapy for stage I/IIE large-cell lymphoma of the stomach

artículo científico publicado en 2000

Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study

artículo científico publicado en 2014

Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers

artículo científico publicado en 2014

Chronic oral etoposide and tamoxifen in the treatment of far-advanced hepatocellular carcinoma

Clinical Activity of Metronomic Chemotherapy in Liver Cancers

Clinical Development and Future Direction for the Treatment of Hepatocellular Carcinoma

article

Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast Cancer

artículo científico publicado en 2016

Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation.

artículo científico publicado en 2012

Clinicopathologic Characteristics of Helicobacter Pyloric Seropositive Gastric Adenocarcinomas

artículo científico publicado en 1995

Clinicopathologic features and responses to radiotherapy of myeloid sarcoma

artículo científico publicado en 2013

Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast--a review of 42 primary and secondary cases in Taiwanese patients

artículo científico publicado en 2009

Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese patients with Ki-1 anaplastic large cell lymphoma: Special emphasis on the tumor response to 13-Cis retinoic acid

article

Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age.

artículo científico publicado en 2003

Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma

artículo científico publicado en 2010

Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma

scientific article published on 18 May 2020

Comparative effectiveness of first-line platinum-based chemotherapy regimens for advanced lung squamous cell carcinoma

artículo científico publicado en 2014

Comparison of MALT and non-MALT primary large cell lymphoma of the stomach: does histologic evidence of MALT affect chemotherapy response?

artículo científico publicado en 2001

Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin

artículo científico

Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence

artículo científico publicado en 2008

Consensus Development from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014).

artículo científico publicado en 2015

Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC).

artículo científico

Corrigendum to "Degradation of Epidermal Growth Factor Receptor Mediates Dasatinib-Induced Apoptosis in Head and Neck Squamous Cell Carcinoma Cells" [Neoplasia 14 (2012) 463-475].

artículo científico publicado en 2017

Corrigendum to "Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma".

artículo científico publicado en 2017

Corrigendum to “Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies” [J hepatol 67 (2017) 999–1008]

scholarly article published in Journal of Hepatology

Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression.

artículo científico publicado en 2015

Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily Practice

scientific article published on 07 July 2016

Degradation of epidermal growth factor receptor mediates dasatinib-induced apoptosis in head and neck squamous cell carcinoma cells

artículo científico publicado en 2012

Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma

artículo científico publicado en 2012

Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: implication from age-period-cohort analysis

artículo científico

Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy

artículo científico

Differential expression of glucocorticoid receptor in carcinomas of the human digestive system.

artículo científico publicado en 2008

Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms

artículo científico publicado en 2006

Direct cardiac effects of As2O3 in rabbits: evidence of reversible chronic toxicity and tissue accumulation of arsenicals after parenteral administration

article

Disseminated peritoneal leiomyomatosis responds to systemic chemotherapy.

artículo científico publicado en 2008

Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer

artículo científico publicado en 2017

Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an East Asian country: a nationwide cancer registry-based study

artículo científico publicado en 2014

Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer

artículo científico publicado en 2016

Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3.

artículo científico publicado en 2011

Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.

artículo científico publicado en 2012

Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells

artículo científico publicado en 2008

Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cells

artículo científico publicado en 2004

Dramatic synergistic anticancer effect of clinically achievable doses of lovastatin and troglitazone

artículo científico publicado en 2006

Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancer

artículo científico publicado en 2014

Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy

artículo científico publicado en 2016

Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil

article

Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy

artículo científico publicado en 2012

E2A-positive gastric MALT lymphoma has weaker plasmacytoid infiltrates and stronger expression of the memory B-cell-associated miR-223: possible correlation with stage and treatment response

artículo científico publicado en 2010

EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment

artículo científico publicado en 2008

Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma

artículo científico publicado en 2010

Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma.

artículo científico publicado en 2016

Effect of thalidomide in hepatocellular carcinoma: assessment with power doppler US and analysis of circulating angiogenic factors

artículo científico publicado en 2005

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2009

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: subset analyses of the phase III Sorafenib Asia-Pacific trial

artículo científico publicado en 2012

Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma

artículo científico publicado en 2007

Efficacy, Safety, and Potential Biomarkers of Thalidomide plus Metronomic Chemotherapy for Advanced Hepatocellular Carcinoma

Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC Study

artículo científico publicado en 2016

Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells

artículo científico publicado en 2010

Erratum to: Corrigendum to "Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma".

artículo científico publicado en 2017

Erratum to: Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: a meta-analysis and meta-regression

scholarly article published in Gastric Cancer

Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter pylori-independent gastric MALT lymphoma

artículo científico publicado en 2011

Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells

artículo científico publicado en 2011

Expression of BCL10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-κB-dependent cyclin D1 signaling

artículo científico publicado en 2012

Expression of MDR-1 Gene in Transitional Cell Carcinoma and its Correlation with Chemotherapy Response

article

Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL.

artículo científico publicado en 2016

FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling

artículo científico publicado en 2008

First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma

artículo científico publicado en 2017

Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy

artículo científico publicado en 2010

Functional characterization of glycine N-methyltransferase and its interactive protein DEPDC6/DEPTOR in hepatocellular carcinoma

artículo científico publicado en 2012

Gastric cancer associated with acute disseminated intravascular coagulation: successful initial treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin.

artículo científico publicado en 1998

Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein

artículo científico publicado en 2005

Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer

artículo científico publicado en 2002

Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: a phase II study

artículo científico publicado en 2007

Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma--a randomized phase II trial

artículo científico publicado en 2008

Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma.

artículo científico publicado en 2009

Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides

artículo científico publicado en 2004

Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma

artículo científico publicado en 2014

Geographic difference in safety and efficacy of systemicchemotherapy for advanced gastric or gastroesophagealcarcinoma: a meta-analysis and meta-regression

artículo científico publicado en 2012

Geographic difference in survival outcome for advanced hepatocellular carcinoma: implications on future clinical trial design

artículo científico publicado en 2009

Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity

Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-{kappa}B activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa

artículo científico publicado en 2006

Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma

artículo científico publicado en 2015

HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity

artículo científico publicado en 2002

Helicobacter pylori CagA Translocation Is Closely Associated With the Expression of CagA-signaling Molecules in Low-grade Gastric Mucosa-associated Lymphoid Tissue Lymphoma

artículo científico publicado en 2015

Helicobacter pylori and mucosa-associated lymphoid tissue: what's new.

artículo científico

Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas

artículo científico publicado en 2012

Helicobacter pylori sensitizes TNF-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human gastric epithelial cells through regulation of FLIP

scientific article published on 06 March 2014

Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity

artículo científico publicado en 2014

Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management

artículo científico publicado en 1995

Hepatitis B virus X protein activates a survival signaling by linking SRC to phosphatidylinositol 3-kinase

artículo científico publicado en 2003

Hepatitis B virus X protein inhibits transforming growth factor-beta -induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway

artículo científico publicado en 2000

Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group

artículo científico publicado en 2013

Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells

artículo científico publicado en 2017

High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country

artículo científico publicado en 2015

High Serum Transforming Growth Factor-β1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib

artículo científico publicado en 2015

High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapy.

artículo científico publicado en 2011

High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma

scientific article published on 01 August 1999

High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy.

artículo científico publicado en 1998

High plasma interleukin-6 levels associated with poor prognosis of patients with advanced hepatocellular carcinoma

artículo científico publicado en 2017

High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers

artículo científico publicado en 1998

High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection

artículo científico publicado en 2002

Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma.

artículo científico publicado en 2012

Hypermethylation of the p16 Gene in Sporadic T3N0M0 Stage Colorectal Cancers: Association with DNA Replication Error and Shorter Survival

article

Identification and characterization of a novel gene Saf transcribed from the opposite strand of Fas.

artículo científico publicado en 2005

Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF kappa B activation

artículo científico publicado en 2002

Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapy

artículo científico publicado en 2002

Increasing Incidence of Brain Metastasis in Patients with Advanced Hepatocellular Carcinoma in the Era of Antiangiogenic Targeted Therapy

artículo científico publicado el 6 de enero de 2011

Induction Chemotherapy With Gemcitabine, Oxaliplatin, and 5-Fluorouracil/Leucovorin Followed by Concomitant Chemoradiotherapy in Patients With Locally Advanced Pancreatic Cancer: A Taiwan Cooperative Oncology Group Phase II Study

Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer

artículo científico publicado en 2009

Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma

artículo científico publicado en 2009

Induction of DNA damage-inducible gene GADD45beta contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells

artículo científico publicado en 2010

Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials

artículo científico publicado en 2011

Infrequent hMSH2 mutations in sporadic gastric adenocarcinoma with microsatellite instability

artículo científico publicado en 1997

Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats

article

Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells.

artículo científico publicado en 2012

Inhibition of CIP2A determines erlotinib-induced apoptosis in hepatocellular carcinoma

artículo científico publicado en 2012

Inhibition of ZEB1 by miR-200 characterizes Helicobacter pylori-positive gastric diffuse large B-cell lymphoma with a less aggressive behavior

artículo científico publicado en 2014

Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma

artículo científico publicado en 2016

Inhibitors of epidermoid growth factor receptor suppress cell growth and enhance chemosensitivity of nasopharyngeal cancer cells in vitro

artículo científico publicado en 2005

Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells

artículo científico publicado en 2004

Involvement of nuclear transcription factor-kappa B in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells

artículo científico publicado en 2003

IκB kinases increase Myc protein stability and enhance progression of breast cancer cells

artículo científico publicado en 2011

KRAS mutation is a predictor of oxaliplatin sensitivity in colon cancer cells

artículo científico publicado en 2012

Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001.

artículo científico publicado en 2011

Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era.

artículo científico publicado en 2011

Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy.

artículo científico publicado en 2017

Liver Cancer Working Group report.

artículo científico publicado en 2010

Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1-2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy.

artículo científico publicado en 2016

Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases

article published in 2014

Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: need for a revisit of surgical treatment.

artículo científico publicado en 2008

Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma

artículo científico publicado en 2005

Low-dose thalidomide treatment for advanced hepatocellular carcinoma

artículo científico publicado en 2003

Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012.

artículo científico publicado en 2012

Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells.

artículo científico publicado en 2013

Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib

artículo científico publicado en 2011

Megestrol acetate antagonizes cisplatin cytotoxicity.

artículo científico publicado en 1998

Menadione-induced DNA damage in a human tumor cell line

artículo científico publicado en 1991

Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma

artículo científico publicado en 2016

Molecular subtypes of breast cancer emerging in young women in Taiwan: evidence for more than just westernization as a reason for the disease in Asia

artículo científico publicado en 2009

Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: the molecular mechanism and the clinical application

artículo científico publicado en 2009

Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma

Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer

artículo científico publicado en 2012

NF-kappaB p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells

artículo científico publicado en 2008

National Policies Fostering Hospice Care Increased Hospice Utilization and Reduced the Invasiveness of End-of-Life Care for Cancer Patients

artículo científico publicado en 2017

Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cells

artículo científico publicado en 2015

No evidence of IGH-MALT1-translocation in the Ma-1 cell line--a reply

artículo científico publicado en 2013

No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen

article

Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group

artículo científico

Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21)

artículo científico publicado en 2005

Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas.

artículo científico publicado en 2004

Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-κB is associated with a poor prognosis of pancreatic cancer

artículo científico publicado en 2013

Nuclear extracellular signal-regulated kinase 2 phosphorylates p53 at Thr55 in response to doxorubicin

artículo científico publicado en 2001

Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: correlation with clinicopathologic features and patient survival

artículo científico

O(6)-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers

artículo científico publicado en 2009

OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma

artículo científico publicado en 2008

Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study

artículo científico publicado en 2017

Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment

artículo científico publicado en 2007

Overexpression of B cell-activating factor of TNF family (BAFF) is associated with Helicobacter pylori-independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma

artículo científico publicado en 2008

Oxaliplatin-based Chemotherapy Might Provide Longer Progression-Free Survival in KRAS Mutant Metastatic Colorectal Cancer

artículo científico publicado en 2013

Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients

artículo científico publicado en 2014

Oxidative stress enhances Axl-mediated cell migration through an Akt1/Rac1-dependent mechanism

artículo científico publicado en 2013

P53 overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection

artículo científico publicado en 2002

Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma

artículo científico publicado en 2011

Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial

artículo científico publicado en 2022

Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer

artículo científico publicado en 2016

Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer

artículo científico publicado en 2006

Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients

artículo científico publicado en 2015

Phase I, pharmacokinetic, and bone marrow drug-level studies of tri-monthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers

artículo científico publicado en 2011

Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer

artículo científico publicado en 2006

Phase II Multicentered Study of Low-Dose Everolimus plus Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as First-Line Treatment for Patients with Advanced Gastric Cancer

Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer

artículo científico publicado en 2009

Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma

artículo científico publicado en 2010

Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer.

artículo científico publicado en 2004

Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer

artículo científico publicado en 2005

Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.

artículo científico publicado en 2002

Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma

artículo científico publicado en 2007

Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)

artículo científico publicado en 2017

Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to Tamoxifen

artículo científico

Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas

artículo científico

Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death

artículo científico publicado en 2004

Polyprenoic Acid in Hepatocellular Carcinoma

scientific article published on 01 November 1996

Postchemoradiotherapy Pathologic Stage Classified by the American Joint Committee on the Cancer Staging System Predicts Prognosis of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma.

artículo científico publicado en 2015

Potentiating the efficacy of molecular targeted therapy for hepatocellular carcinoma by inhibiting the insulin-like growth factor pathway

artículo científico publicado en 2013

Predictive and Prognostic Values of Tau and ERCC1 in Advanced Breast Cancer Patients Treated with Paclitaxel and Cisplatin

artículo científico publicado en 2010

Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?

artículo científico publicado en 2015

Preoperative prognostic neurologic index for glioblastoma patients receiving tumor resection

artículo científico publicado en 2014

Prescription Patterns of Sorafenib and Outcomes of Patients with Advanced Hepatocellular Carcinoma: A National Population Study

artículo científico publicado en 2017

Primary Squamous Cell Carcinoma of the Thyroid With Cardiac Metastases and Right Ventricle Outflow Tract Obstruction

article published in 2012

Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: complete response to combined intrathecal and systemic rituximab

article

Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart

artículo científico publicado en 2015

Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: a nationwide cohort study

artículo científico publicado en 2016

Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems.

artículo científico publicado en 2012

Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy

artículo científico publicado en 2013

Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens

Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies

artículo científico publicado en 2017

Prognostic factors in extrapulmonary small cell carcinomas. A large retrospective study

artículo científico publicado en 2007

Prognostic molecular markers in women aged 35 years or younger with breast cancer: is there a difference from the older patients?

artículo científico

Prognostic value of multidrug resistance 1, glutathione-S-transferase-pi and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy

artículo científico publicado en 2002

Promoter polymorphisms of tumor necrosis factor-alpha are associated with risk of gastric mucosa-associated lymphoid tissue lymphoma

artículo científico publicado en 2004

Pursuing efficacious systemic therapy for hepatocellular carcinoma

artículo científico publicado en 2021

Quiescent nasal T/NK cell lymphoma manifested as primary central nervous system lymphoma.

artículo científico publicado en 1999

Radiation-induced hepatitis B virus reactivation in liver mediated by the bystander effect from irradiated endothelial cells

artículo científico publicado en 2007

Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size

artículo científico publicado en 2013

Radiosensitization by combining an aurora kinase inhibitor with radiotherapy in hepatocellular carcinoma through cell cycle interruption

artículo científico publicado en 2014

Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinoma

artículo científico publicado en 2012

Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study.

artículo científico publicado en 2013

Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma

artículo científico publicado en 2016

Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: Consensus recommendations and review by an International Expert Panel.

artículo científico publicado en 2013

Recent advances in the prevention of hepatocellular carcinoma recurrence

artículo científico publicado en 2014

Recent advances in the treatment of metastatic colorectal cancer in Taiwan

scientific article published on January 2011

Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia

artículo científico publicado en 2008

Redesigning graduate medical education--location and content

artículo científico publicado en 1996

Redesigning graduate medical education--location and content

artículo científico publicado en 1996

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

artículo científico publicado en 2016

Relapse Pattern and Treatment Outcome of Curative Radiotherapy for Primary Cutaneous CD30+ Anaplastic Large-cell Lymphoma: A Retrospective Cohort Study

artículo científico publicado en 2015

Relatively low expression of multidrug resistance-1 (MDR-1) and its possible clinical implication in gastric cancers.

artículo científico publicado en 1998

Reply

Reply to: "Predictors of sorafenib benefit in patients with hepatocellular carcinoma".

artículo científico publicado en 2017

Retinoic acid-induced apoptotic pathway in T-cell lymphoma: Identification of four groups of genes with differential biological functions

artículo científico publicado en 2000

Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study

artículo científico publicado en 2009

Safety and efficacy of tigatuzumab plus sorafenib as first-line therapy in subjects with advanced hepatocellular carcinoma: A phase 2 randomized study

artículo científico publicado en 2015

Serum Insulin-Like Growth Factor-1 Levels Predict Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Antiangiogenic Therapy

artículo científico publicado en 2012

Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma

artículo científico publicado en 2011

Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC.

artículo científico publicado en 2010

Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: implications from age-period-cohort analysis

artículo científico

Somatic mutations in epidermal growth factor receptor underlying complete responsiveness to gefitinib in a Taiwanese female patient with metastatic adenocarcinoma of lung

artículo científico publicado en 2005

Sonic Hedgehog inhibition as a strategy to augment radiosensitivity of hepatocellular carcinoma

artículo científico publicado en 2015

Sorafenib Enhances Radiation-Induced Apoptosis in Hepatocellular Carcinoma by Inhibiting STAT3

Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody

artículo científico publicado en 2013

Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf.

artículo científico publicado en 2011

Sorafenib for the treatment of hepatocellular carcinoma across geographic regions

artículo científico publicado en 2009

Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3.

artículo científico publicado en 2010

Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity.

artículo científico publicado en 2013

Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy

artículo científico publicado en 2008

Stability of curcumin in buffer solutions and characterization of its degradation products.

artículo científico publicado en 1997

Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan

artículo científico publicado en 2015

Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma

artículo científico publicado en 2003

Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy

artículo científico publicado en 2009

Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL.

artículo científico publicado en 2007

Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-kappaB activation by protein phosphatase 4-mediated NF-kappaB p65 Thr dephosphorylation

artículo científico publicado en 2004

Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials

Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and Paclitaxel as first-line treatment.

artículo científico publicado en 2005

Survival-weighted health profile for long-term survivors of acute myelogenous leukemia.

artículo científico publicado en 2003

Synergistic Blockade of EGFR and HER2 by New-Generation EGFR Tyrosine Kinase Inhibitor Enhances Radiation Effect in Bladder Cancer Cells

artículo científico publicado en 2015

Synergistic effect of radiation and interleukin-6 on hepatitis B virus reactivation in liver through STAT3 signaling pathway

artículo científico publicado en 2009

Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation

artículo científico publicado en 2009

Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: a pilot study of the BOMES protocol

artículo científico publicado en 1998

TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays

artículo científico publicado en 2015

Tamoxifen Enhances the Chemosensitivity of Bladder Carcinoma Cells

Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma

artículo científico publicado en 2012

Targeting fibroblast growth factor receptor signaling in hepatocellular carcinoma

artículo científico publicado en 2011

Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice

artículo científico publicado en 2017

Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma

artículo científico publicado en 2017

Tax of the human T-lymphotropic virus type I transactivates promoter of the MDR-1 gene

artículo científico publicado en 1997

The Akt inhibitor MK-2206 enhances the cytotoxicity of paclitaxel (Taxol) and cisplatin in ovarian cancer cells

artículo científico publicado en 2014

The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma

artículo científico publicado en 2008

The Aurora kinases inhibitor VE-465 is a novel treatment for glioblastoma multiforme

artículo científico publicado en 2013

The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21).

artículo científico publicado en 2016

The Prognostic Impact of Type 2 Diabetes Mellitus on Early Cervical Cancer in Asia

artículo científico publicado en 2015

The Response, Outcome and Toxicity of Aggressive Palliative Thoracic Radiotherapy for Metastatic Non-Small Cell Lung Cancer Patients with Controlled Extrathoracic Diseases

artículo científico publicado en 2015

The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells

artículo científico publicado en 2002

The emerging epidemic of estrogen-related cancers in young women in a developing Asian country

artículo científico publicado en 2011

The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: a comparative study of the efficacy of anthracyclines and non-anthracyclines

artículo científico publicado en 2013

The germline BIM deletion polymorphism is not associated with the treatment efficacy of sorafenib in patients with advanced hepatocellular carcinoma

artículo científico publicado en 2013

The impact of diabetes mellitus on prognosis of early breast cancer in Asia

artículo científico publicado en 2012

The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer

artículo científico publicado en 2015

The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cells

artículo científico publicado en 2010

Tissue distribution of arsenic species in rabbits after single and multiple parenteral administration of arsenic trioxide: tissue accumulation and the reversibility after washout are tissue-selective

article

Transactivation of the human MDR1 gene by hepatitis B virus X gene product

artículo científico publicado en 1998

Translocation of Helicobacter pylori CagA into Human B lymphocytes, the origin of mucosa-associated lymphoid tissue lymphoma

artículo científico publicado en 2010

Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: a meta-analysis of randomized clinical trials

artículo científico publicado en 2015

Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma

scientific article published on 16 August 2016

Tumor compactness improves the preoperative volumetry-based prediction of the pathological complete response of rectal cancer after preoperative concurrent chemoradiotherapy

artículo científico publicado en 2016

Type 2 diabetes mellitus is associated with increased mortality in Chinese patients receiving curative surgery for colon cancer

artículo científico publicado en 2014

Unusual presentation of multiple pathologic bone fractures in a patient with gastric mucosa-associated lymphoid tissue lymphoma.

artículo científico publicado en 2009

Updated results from GEST study: a randomized, three-arm phase III study for advanced pancreatic cancer

artículo científico publicado en 2017

Vandetanib in patients with inoperable hepatocellular carcinoma: a phase II, randomized, double-blind, placebo-controlled study

artículo científico publicado en 2012

Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivin

artículo científico publicado en 2014

Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: an effective regimen with low toxicity

artículo científico publicado en 2006

Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: in vitro combined effects and a phase II trial

artículo científico publicado en 2007

Young patients with colorectal cancer have increased risk of second primary cancers

artículo científico publicado en 2015

mRECIST to predict survival in advanced hepatocellular carcinoma: Analysis of two randomised phase II trials comparing nintedanib vs sorafenib

artículo científico publicado en 2017

t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement.

artículo científico publicado en 2011

β-catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma

artículo científico publicado en 2014